Manuscript Type: Original Article
Title: Phase 1 Study of Cabozantinib in Combination with Topotecan- Cyclophosphamide for Patients with Relapsed Ewing Sarcoma or Osteosarcoma
Authors: Kevin Campbell, MD1*, Andrew Posner1, Nan Chen1, Kerri Cavanaugh, RN1; Ketki Bhushan1, Katherine A. Janeway, MD1, David S. Shulman, MD1, Suzanne George, MD2, Kelly Klega, Brian Crompton, MD, Wendy B. London, PhD1, Steven G. DuBois, MD MS1
Author Affiliations: 1Dana-Farber / Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; 2Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
*Current Affiliation: Children’s Mercy Hospital, Department of Hematology, Oncology, Kansas City, MO